Uterine arterial embolization: Factors influencing patient radiation exposure

R. T. Andrews, Paul Brown

Research output: Contribution to journalArticle

64 Citations (Scopus)

Abstract

PURPOSE: To investigate patient radiation exposures during uterine arterial embolization and the factors responsible for those exposures. MATERIALS AND METHODS: Clinical and procedural factors were evaluated for 42 consecutive procedures performed in 39 patients by one operator. Seven patients were excluded because of early termination (n = 1) or unusual conditions that necessitated extended procedures (n = 6). Fluoroscopic time, number of images acquired, height, and weight were available in the 35 remaining patients, and dose-area product (DAP) was available in 20. Equipment factors were evaluated by using a Lucite phantom in four angiography units from three manufacturers. RESULTS: The mean fluoroscopic time per case decreased from 30.6 to 14.2 minutes between the 1st and 5th quintiles. Mean DAP decreased from 211.4 to 30.6 Gy · cm2 with dose reduction techniques; this primarily reflected a decreased number of acquired images. Phantom studies demonstrated many significant dose variations with magnification and equipment position. Low-dose and pulsed fluoroscopic modes reduced exposure rates in units so equipped, but roadmapping caused a silent switch to continuous fluoroscopy in two such units, which doubled the exposure rate. CONCLUSION: With operator experience and careful technique, uterine arterial embolization can be performed at radiation exposures comparable to those used in routine diagnostic studies. However, operators must be familiar with the technical parameters of their angiographic equipment.

Original languageEnglish (US)
Pages (from-to)713-722
Number of pages10
JournalRadiology
Volume217
Issue number3
StatePublished - 2000

Fingerprint

Equipment and Supplies
Fluoroscopy
Polymethyl Methacrylate
Angiography
Weights and Measures
Radiation Exposure

Keywords

  • Arteries, therapeutic embolization
  • Dosimetry Leiomyoma
  • Radiations, exposure to patients and personnel
  • Uterine neoplasms, therapy

ASJC Scopus subject areas

  • Radiological and Ultrasound Technology

Cite this

Uterine arterial embolization : Factors influencing patient radiation exposure. / Andrews, R. T.; Brown, Paul.

In: Radiology, Vol. 217, No. 3, 2000, p. 713-722.

Research output: Contribution to journalArticle

Andrews, RT & Brown, P 2000, 'Uterine arterial embolization: Factors influencing patient radiation exposure', Radiology, vol. 217, no. 3, pp. 713-722.
Andrews, R. T. ; Brown, Paul. / Uterine arterial embolization : Factors influencing patient radiation exposure. In: Radiology. 2000 ; Vol. 217, No. 3. pp. 713-722.
@article{6fa6294867fa455fa006a92970409182,
title = "Uterine arterial embolization: Factors influencing patient radiation exposure",
abstract = "PURPOSE: To investigate patient radiation exposures during uterine arterial embolization and the factors responsible for those exposures. MATERIALS AND METHODS: Clinical and procedural factors were evaluated for 42 consecutive procedures performed in 39 patients by one operator. Seven patients were excluded because of early termination (n = 1) or unusual conditions that necessitated extended procedures (n = 6). Fluoroscopic time, number of images acquired, height, and weight were available in the 35 remaining patients, and dose-area product (DAP) was available in 20. Equipment factors were evaluated by using a Lucite phantom in four angiography units from three manufacturers. RESULTS: The mean fluoroscopic time per case decreased from 30.6 to 14.2 minutes between the 1st and 5th quintiles. Mean DAP decreased from 211.4 to 30.6 Gy · cm2 with dose reduction techniques; this primarily reflected a decreased number of acquired images. Phantom studies demonstrated many significant dose variations with magnification and equipment position. Low-dose and pulsed fluoroscopic modes reduced exposure rates in units so equipped, but roadmapping caused a silent switch to continuous fluoroscopy in two such units, which doubled the exposure rate. CONCLUSION: With operator experience and careful technique, uterine arterial embolization can be performed at radiation exposures comparable to those used in routine diagnostic studies. However, operators must be familiar with the technical parameters of their angiographic equipment.",
keywords = "Arteries, therapeutic embolization, Dosimetry Leiomyoma, Radiations, exposure to patients and personnel, Uterine neoplasms, therapy",
author = "Andrews, {R. T.} and Paul Brown",
year = "2000",
language = "English (US)",
volume = "217",
pages = "713--722",
journal = "Radiology",
issn = "0033-8419",
publisher = "Radiological Society of North America Inc.",
number = "3",

}

TY - JOUR

T1 - Uterine arterial embolization

T2 - Factors influencing patient radiation exposure

AU - Andrews, R. T.

AU - Brown, Paul

PY - 2000

Y1 - 2000

N2 - PURPOSE: To investigate patient radiation exposures during uterine arterial embolization and the factors responsible for those exposures. MATERIALS AND METHODS: Clinical and procedural factors were evaluated for 42 consecutive procedures performed in 39 patients by one operator. Seven patients were excluded because of early termination (n = 1) or unusual conditions that necessitated extended procedures (n = 6). Fluoroscopic time, number of images acquired, height, and weight were available in the 35 remaining patients, and dose-area product (DAP) was available in 20. Equipment factors were evaluated by using a Lucite phantom in four angiography units from three manufacturers. RESULTS: The mean fluoroscopic time per case decreased from 30.6 to 14.2 minutes between the 1st and 5th quintiles. Mean DAP decreased from 211.4 to 30.6 Gy · cm2 with dose reduction techniques; this primarily reflected a decreased number of acquired images. Phantom studies demonstrated many significant dose variations with magnification and equipment position. Low-dose and pulsed fluoroscopic modes reduced exposure rates in units so equipped, but roadmapping caused a silent switch to continuous fluoroscopy in two such units, which doubled the exposure rate. CONCLUSION: With operator experience and careful technique, uterine arterial embolization can be performed at radiation exposures comparable to those used in routine diagnostic studies. However, operators must be familiar with the technical parameters of their angiographic equipment.

AB - PURPOSE: To investigate patient radiation exposures during uterine arterial embolization and the factors responsible for those exposures. MATERIALS AND METHODS: Clinical and procedural factors were evaluated for 42 consecutive procedures performed in 39 patients by one operator. Seven patients were excluded because of early termination (n = 1) or unusual conditions that necessitated extended procedures (n = 6). Fluoroscopic time, number of images acquired, height, and weight were available in the 35 remaining patients, and dose-area product (DAP) was available in 20. Equipment factors were evaluated by using a Lucite phantom in four angiography units from three manufacturers. RESULTS: The mean fluoroscopic time per case decreased from 30.6 to 14.2 minutes between the 1st and 5th quintiles. Mean DAP decreased from 211.4 to 30.6 Gy · cm2 with dose reduction techniques; this primarily reflected a decreased number of acquired images. Phantom studies demonstrated many significant dose variations with magnification and equipment position. Low-dose and pulsed fluoroscopic modes reduced exposure rates in units so equipped, but roadmapping caused a silent switch to continuous fluoroscopy in two such units, which doubled the exposure rate. CONCLUSION: With operator experience and careful technique, uterine arterial embolization can be performed at radiation exposures comparable to those used in routine diagnostic studies. However, operators must be familiar with the technical parameters of their angiographic equipment.

KW - Arteries, therapeutic embolization

KW - Dosimetry Leiomyoma

KW - Radiations, exposure to patients and personnel

KW - Uterine neoplasms, therapy

UR - http://www.scopus.com/inward/record.url?scp=0033708437&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033708437&partnerID=8YFLogxK

M3 - Article

C2 - 11110933

AN - SCOPUS:0033708437

VL - 217

SP - 713

EP - 722

JO - Radiology

JF - Radiology

SN - 0033-8419

IS - 3

ER -